As we have informed last 15 November 2022 here, Hangzhou GreatStar Industrial, whose A Shares are listed on the Shenzhen Stock Exchange, became the eighth Chinese company that has listed global depositary receipts (GDRs) on the SIX Swiss Exchange. Hangzhou GreatStar Industrial issued and listed 11,812,700 GDRs at an offer price of USD 13.08 per […]
Search Results for: vischer
Anokion, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. Founded in Switzerland and based on innovation from the EPFL Life Sciences, Anokion is led by a diverse team of entrepreneurial scientists and experienced […]
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be drawn down in multiple tranches. Based in Lausanne, Lunaphore Technologies has developed a game-changing chip technology which can extract […]
Bratschi has appointed three new partners and of counsel on its Basel’s office. Marco Giavarini, Marius Meier and Orlando Meyer have been appointed partners and Christop Grether, of counsel. Marco Giavarini advises clients primarily in the area of real estate law. One focus of his practice is landlord and tenant law, where he mainly represents […]
Cembra Money Bank, a renowed Swiss provider of financing solutions and services, has announced that it has agreed to acquire a 100% stake in Byjuno and its sister company, Intrum Finance Services, from Intrum for a purchase price of CHF 60 million. This acquisition is further step in expanding its embedded finance product suite and […]
Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio with a Phase 2 ready programme based on first-in-class scanning liposome technology, a paediatric programme focused on urea cycle disorder […]
VISCHER has advised Forty51 Ventures, a Biotech venture capital firm, on its first fund, Forty51 Ventures Fund I which has raised USD 43 million in a first closing and is domiciled in Luxemburg. VISCHER has supported, in particular, regarding the setting up of Forty51 Advisory, in Basel which renders advisory services to the Fund. As […]
The management of Roventa-Henex has acquired 60% of the share capital of the company. The manufacturer of quality Swiss Made Private Label watches also designs, develops and distributes private label watches and related components. It was founded in 1959 by Norbert Schenkel in Biel. The Munich-based Findos Investor, an independent mid-market private equity fund, retains […]
VISCHER has advised EBL on the sale of its Telekom division to Sunrise. EBL has been active in the telecom business since 2000 and owns telecom networks in around 200 communities in Switzerland. At the same time, EBL has been successfully pursuing a strong expansion of its business with renewable energy, heat production and distribution […]
As we have informed last 28th July, Keda Industrial Group and Ningbo Shanshan were among the first companies which successfully listed global depositary receipts (GDRs) on SIX Swiss Exchange. Keda Industrial Group, whose A shares are listed on the Shanghai Stock Exchange, raised gross proceeds in the amount of approx. USD 173 mio. from the offering of GDRs and Ningbo Shanshan, […]
